Influence of molecular weight on oral absorption of water soluble chitosans

被引:313
作者
Chae, SY [1 ]
Jang, MK [1 ]
Nah, JW [1 ]
机构
[1] Sunchon Natl Univ, Dept Polymer Sci & Engn, Sunchon 540742, Jeonnam, South Korea
关键词
chitosan; oral absorption; molecular weight; caco-2; cell; permeability;
D O I
10.1016/j.jconrel.2004.10.012
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chitosan, a cationic polysaccharide, has been widely employed as dietary supplement and in pharmacological and biomedical applications. Although numerous studies have focused on its applications as pharmaceutical excipients or bioactive reagents, molecular weight (MW)-dependent pharmaceutical and bioactive properties remain unclear. As a preliminary study, we investigated the NW-dependent Caco-2 cell layer transport phenomena (in vitro) and intestinal absorption patterns after oral administration (in vivo) of water-soluble chitosans (WSCs). The absorption of chitosan was significantly influenced by its MW. As the MW increases, the absorption decreases. Compared to high-MW chitosan (WSC 230K, MW=230 kDa), absorption profiles were observed to increase more than 23 and 25 times with WSC 3.8K (MW=3.8 kDa) in both in vitro and in vivo transport experiments, respectively. Furthermore, the chitosans showed concentration- and MW-dependent cytotoxic effects, and the chitosan oligosaccharides (MW<10 kDa) showed negligible cytotoxic effect on the Caco-2 cells. In consideration with safety and absorption profiles, chitosan oligosaccharides may be considered as safe and potential candidates for pharmaceutical and biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:383 / 394
页数:12
相关论文
共 35 条
  • [1] Small particles of a heparin/chitosan complex prepared from a pharmaceutically acceptable microemulsion
    Andersson, M
    Löfroth, JE
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 257 (1-2) : 305 - 309
  • [2] IN-VITRO CYTOTOXICITY OF MACROMOLECULES IN DIFFERENT CELL-CULTURE SYSTEMS
    CHOKSAKULNIMITR, S
    MASUDA, S
    TOKUDA, H
    TAKAKURA, Y
    HASHIDA, M
    [J]. JOURNAL OF CONTROLLED RELEASE, 1995, 34 (03) : 233 - 241
  • [3] COAKLEY WT, 1985, EUR BIOPHYS J BIOPHY, V13, P123
  • [4] Effect of chitosan on epithelial permeability and structure
    Dodane, V
    Khan, MA
    Merwin, JR
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (01) : 21 - 32
  • [5] Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles
    Dyer, AM
    Hinchcliffe, M
    Watts, P
    Castile, J
    Jabbal-Gill, I
    Nankervis, R
    Smith, A
    Illum, L
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (07) : 998 - 1008
  • [6] Enhancement of nasal absorption of insulin using chitosan nanoparticles
    Fernández-Urrusuno, R
    Calvo, P
    Remuñán-López, C
    Vila-Jato, JL
    Alonso, MJ
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (10) : 1576 - 1581
  • [7] Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats
    Gallaher, CM
    Munion, J
    Hesslink, R
    Wise, J
    Gallaher, DD
    [J]. JOURNAL OF NUTRITION, 2000, 130 (11) : 2753 - 2759
  • [8] Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice
    Hayashi, K
    Ito, M
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (02) : 188 - 192
  • [9] Chitosan-based gastrointestinal delivery systems
    Hejazi, R
    Amiji, M
    [J]. JOURNAL OF CONTROLLED RELEASE, 2003, 89 (02) : 151 - 165
  • [10] Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7